Thermo Fisher Scientific, Inc. (TMO)
696.92
+12.03
(+1.76%)
USD |
NYSE |
Oct 27, 14:30
Thermo Fisher Scientific EPS Diluted (Quarterly) : 4.64 for Sept. 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 4.64 |
| June 30, 2026 | 4.679 |
| March 31, 2026 | 4.426 |
| December 31, 2025 | 5.210 |
| September 30, 2025 | 4.275 |
| June 30, 2025 | 4.278 |
| March 31, 2025 | 3.976 |
| December 31, 2024 | 4.778 |
| September 30, 2024 | 4.245 |
| June 30, 2024 | 4.042 |
| March 31, 2024 | 3.458 |
| December 31, 2023 | 4.201 |
| September 30, 2023 | 4.420 |
| June 30, 2023 | 3.508 |
| March 31, 2023 | 3.322 |
| December 31, 2022 | 4.010 |
| September 30, 2022 | 3.785 |
| June 30, 2022 | 4.223 |
| March 31, 2022 | 5.608 |
| December 31, 2021 | 4.166 |
| September 30, 2021 | 4.791 |
| June 30, 2021 | 4.616 |
| March 31, 2021 | 5.887 |
| December 31, 2020 | 6.245 |
| September 30, 2020 | 4.845 |
| Date | Value |
|---|---|
| June 30, 2020 | 2.904 |
| March 31, 2020 | 1.97 |
| December 31, 2019 | 2.492 |
| September 30, 2019 | 1.881 |
| June 30, 2019 | 2.777 |
| March 31, 2019 | 2.022 |
| December 31, 2018 | 2.22 |
| September 30, 2018 | 1.746 |
| June 30, 2018 | 1.85 |
| March 31, 2018 | 1.43 |
| December 31, 2017 | 1.30 |
| September 30, 2017 | 1.335 |
| June 30, 2017 | 1.56 |
| March 31, 2017 | 1.40 |
| December 31, 2016 | 1.59 |
| September 30, 2016 | 1.19 |
| June 30, 2016 | 1.30 |
| March 31, 2016 | 1.01 |
| December 31, 2015 | 1.50 |
| September 30, 2015 | 1.18 |
| June 30, 2015 | 1.27 |
| March 31, 2015 | 0.96 |
| December 31, 2014 | 1.49 |
| September 30, 2014 | 1.17 |
| June 30, 2014 | 0.69 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Agilent Technologies, Inc. | 1.279 |
| Danaher Corp. | 1.747 |
| Illumina, Inc. | 1.353 |
| Bio-Rad Laboratories, Inc. | 13.85 |
| Revvity, Inc. | 0.4642 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 1.739B |
| Revenue (Quarterly) | 12.14B |
| Total Expenses (Quarterly) | 10.40B |
| Enterprise Value | 288.67B |
| Gross Profit Margin (Quarterly) | 38.50% |
| Profit Margin (Quarterly) | 14.33% |
| Earnings Yield | 2.72% |
| Operating Earnings Yield | 3.52% |